Cyclopharm Ltd

NEW
ASX:CYC (Australia)  
A$ 0.50 (0%) Jun 26
At Loss
P/B:
2.05
Market Cap:
A$ 63.03M ($ 44.41M)
Enterprise V:
A$ 64.15M ($ 45.19M)
Volume:
127.88K
Avg Vol (2M):
159.92K
Trade In:
Volume:
127.88K
At Loss
Avg Vol (2M):
159.92K

Business Description

Description
Cyclopharm Ltd is a health technology company offering solutions related to functional lung ventilation imaging. Its proprietary product Technegas is a broad-spectrum diagnostic lung imaging technology product for the visualisation of pulmonary ventilation and lung function. The company sells its products to healthcare institutions and medical professionals. Maximum revenue is generated from its Technegas products and services, which include the sale of diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism and other respiratory conditions. Geographically, the company generates maximum revenue from its business in Europe, and the rest from Asia Pacific, Canada, the USA, and other regions.
Name Current Vs Industry Vs History
Cash-To-Debt
0.86
Equity-to-Asset
0.59
Debt-to-Equity
0.29
Debt-to-EBITDA
-0.48
Piotroski F-Score
2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score
-0.45
Distress
Grey
Safe
Beneish M-Score
-1.94
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI
21.59
9-Day RSI
22.84
14-Day RSI
25.61
3-1 Month Momentum %
-5.41
6-1 Month Momentum %
-27.46
12-1 Month Momentum %
-23.08

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
2.53
Quick Ratio
1.51
Cash Ratio
0.59
Days Inventory
326.71
Days Sales Outstanding
149.44
Days Payable
129.23

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-6.1
Shareholder Yield %
-1.48

Financials

ASX:CYC's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Cyclopharm Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil A$) 16.692
EPS (TTM) (A$) -0.157
Beta 1.3775
3-Year Sharpe Ratio -0.34
3-Year Sortino Ratio -0.46
Volatility % 66.53
14-Day RSI 25.61
14-Day ATR (A$) 0.029083
20-Day SMA (A$) 0.58025
12-1 Month Momentum % -23.08
52-Week Range (A$) 0.47 - 1.29
Shares Outstanding (Mil) 126.07

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Cyclopharm Ltd Filings

Filing Date Document Date Form
No Filing Data

Cyclopharm Ltd Stock Events

Financials Calendars
Event Date Price (A$)
0.2:1 Stock Split 2012-05-28 0.22 (+0.00%)
1:1 Stock Split 2008-10-21 0.46 (+0.00%)
Show
Entries

Cyclopharm Ltd Frequently Asked Questions

What is Cyclopharm Ltd(ASX:CYC)'s stock price today?
The current price of ASX:CYC is A$0.50. The 52 week high of ASX:CYC is A$1.29 and 52 week low is A$0.47.
When is next earnings date of Cyclopharm Ltd(ASX:CYC)?
The next earnings date of Cyclopharm Ltd(ASX:CYC) is .
Does Cyclopharm Ltd(ASX:CYC) pay dividends? If so, how much?
Cyclopharm Ltd(ASX:CYC) does not pay dividend.

Press Release

Subject Date
No Press Release

Articles on Cyclopharm Ltd

No articles.